New uterine sampler aims to make cancer detection less painful

NCT ID NCT04258449

First seen Sep 30, 2025 · Last updated May 15, 2026 · Updated 29 times

Summary

This study tests a new tool called the DOvEEgene Fleur that collects cells from inside the uterus to detect cancers of the endometrium, tubes, and ovaries early. The goal is to see if it causes less pain than the current brush while still getting enough cells for accurate testing. About 40 women with suspected or confirmed gynecological cancer will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WOMEN WITH SUSPECTED OR CONFIRMED GYNECOLOGICAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Royal Victoria Hospital (Glen Site)

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.